Overview:
The global optical imaging market is anticipated to undergo double-digit growth through 2023. Technological development in imaging technologies has been the greatest phenomenon witnessed in this market during the last few years. The global optical imaging market is mainly driven by increase in demand for non-invasive diagnostic alternatives, growing applications of optical imaging in therapeutic, diagnostic and translational research. On the other hand, high costs and requirement for long-term data for efficient commercialization of these technologies, lack of skilled technicians, and rigid government regulations may hold back the growth of this market.
In terms of regional distribution, the global optical imaging market is dominated by North America and Europe regions. These regions will undergo rapid market growth due to their higher purchasing capacity and tendency of rapidly adopting technically advanced solutions. Domicile of several manufactures in these regions will also contribute to their dominance. The high growth of Asia-Pacific and Latin America markets is majorly due to development of biotechnology and pharmaceuticals sectors, development of healthcare infrastructure and growing awareness.
The top five players in the global optical imaging market accounts for more than 60% of the market share. However, the intense competition by existing small-sized and mid- sized players in the market is threatening the market share of top players. In order to maintain their share, leading players are continuously embracing new technologies and striving to develop advanced products into the market. This increasing innovation in the market is helping the industry to solve existing challenges and to meet the unmet needs of the market.
Some prominent players in the global market are Topcon Medical systems, Inc. (U.S.), St.Jude Medical, Inc. (U.S.), Carl Zeiss Meditec AG (Germany), and Bioptigen, Inc. (U.S.). In addition to these major players, there are more than 30 players in the global market, including Heidelberg Engineering, Inc. (U.S.), Headwall Photonics, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Optovue, Inc. (U.S.), DermaLumics (Spain), Michelson Diagnostics (U.K.), AGFA Healthcare (Belgium), and Santec Corporation (Japan).
The global optical imaging market is segmented on the following bases:
1. Techniques
a. Optical Coherence Tomography
b. Hyperspectral Imaging
c. Near-infrared Spectroscopy
d. Photoacoustic Tomography
2. Products
a. Imaging Systems
b. Cameras
c. Software
d. Illumination Systems
e. Lenses
f. Others
3. Therapeutic Area
a. Ophthalmology
b. Neurology
c. Oncology
d. Cardiology
e. Dermatology
f. Others
4. Application
a. Pathological Imaging
b. Intra-operative Imaging
5. End-Users
a. Hospitals & Clinics
b. Research Laboratories
c. Pharmaceuticals and Biotechnology
6. Geography
a. North America
i. US
ii. Canada
b. Europe
i. UK
ii. Germany
iii. Rest of Europe
c. Asia-Pacific
i. Japan
ii. China
iii. Rest of APAC
d. Latin America
e. Middle East and Africa
Key players identified for optical imaging market include but are not limited to:
Topcon Medical systems, Inc.,St.Jude Medical, Inc., Carl Zeiss Meditec AG,Bioptigen, Inc., Heidelberg Engineering, Inc., Headwall Photonics, Inc., PerkinElmer, Inc., Optovue, Inc., DermaLumics, Michelson Diagnostics, AGFA Healthcare, Santec Corporationand others.
This report offers:
